Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on April 3, 2003

Stroke. 2003
Published online before print April 3, 2003, doi: 10.1161/01.STR.0000068406.30514.31
A more recent version of this article appeared on May 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/5/1235    most recent
01.STR.0000068406.30514.31v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alvarez-Sabín, J.
Right arrow Articles by Quintana, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alvarez-Sabín, J.
Right arrow Articles by Quintana, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Fibrinolysis
Right arrow Acute Cerebral Infarction
Right arrow Thrombolysis

Submitted on November 2, 2002
Accepted on December 4, 2002

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients

José Alvarez-Sabín MD, PhD*; Carlos A. Molina MD, PhD; Joan Montaner MD, PhD; Juan F. Arenillas MD; Rafael Huertas MD; Marc Ribo MD; Agusti Codina MD, PhD; and Manuel Quintana

From the Cerebrovascular Unit, Department of Neurology, Hospital Vall d‘Hebrón, Barcelona, Spain.

* To whom correspondence should be addressed. E-mail: alsa{at}hg.vhebron.es.

Background and Purpose--We sought to investigate the impact of hyperglycemia before reperfusion on long-term outcome in patients treated with intravenous tissue plasminogen activator (tPA).

Methods--Of 268 consecutive patients with a nonlacunar middle cerebral artery (MCA) stroke evaluated at <3 hours after onset, 73 (27.2%) received intravenous tPA. Serum glucose was determined at baseline before tPA administration. Hyperglycemia was defined as a glucose level >140 mg/dL. National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and 24 hours. Transcranial Doppler monitoring of recanalization and reocclusion was conducted during the first 24 hours. Total infarct volume was measured on CT at day 5 to 7. Modified Rankin Scale was used to assess outcome at 3 months.

Results--Median NIHSS score was 17. At baseline, 31 patients (42.5%) were hyperglycemic and 42 (57.5%) normoglycemic. Early reperfusion (<6 hours) occurred in 43 patients (58.9%). Admission blood glucose correlated negatively with the degree of neurological improvement at 24 hours in reperfused (r=-0.43; P=0.019) but not in nonreperfused (r=-0.20; P=0.21) tPA-treated patients. Increased age (P=0.014), history of diabetes mellitus (P=0.043), admission glucose >140 mg/dL (P=0.002), and early reocclusion (P=0.004) were factors associated with poor outcome among reperfused patients. A logistic regression modeling revealed that only admission glucose value >140 mg/dL (odds ratio, 8.4; 95% CI, 1.76 to 40.02; P=0.005) emerged as an independent predictor of poor outcome despite tPA-induced recanalization. In patients with 6-hour persistent MCA occlusion, baseline NIHSS score >15 points (P=0.011) and proximal MCA occlusion (P=0.039) were variables associated with poor outcome on univariate analysis. In a logistic regression model, only NIHSS score >15 points (odds ratio, 11.9; 95% CI, 1.48 to 97.1; P=0.032) remained as an independent predictor of poor outcome and functional dependence at 3 months in nonreperfused tPA-treated patients.

Conclusions--Hyperglycemia before reperfusion may in part counterbalance the beneficial effect of early restoration of blood flow, which translates into a worse outcome in hyperglycemic patients despite tPA-induced recanalization.


Key words: disease progression • hyperglycemia • outcome • thrombolysis • ultrasonography




This article has been cited by other articles:


Home page
StrokeHome page
A. W. Asimos
Guidelines For Extending the Tissue Plasminogen Activator Treatment Window for Ischemic Stroke
Stroke, November 1, 2009; 40(11): e633 - e633.
[Full Text] [PDF]


Home page
Age AgeingHome page
N. Kostulas, I. Markaki, H. Cansu, T. Masterman, and V. Kostulas
Hyperglycaemia in acute ischaemic stroke is associated with an increased 5-year mortality
Age Ageing, September 1, 2009; 38(5): 590 - 594.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Summers, A. Leonard, D. Wentworth, J. L. Saver, J. Simpson, J. A. Spilker, N. Hock, E. Miller, P. H. Mitchell, and on behalf of the American Heart Association Counci
Comprehensive Overview of Nursing and Interdisciplinary Care of the Acute Ischemic Stroke Patient: A Scientific Statement From the American Heart Association
Stroke, August 1, 2009; 40(8): 2911 - 2944.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. Y. Poppe, S. R. Majumdar, T. Jeerakathil, W. Ghali, A. M. Buchan, M. D. Hill, and the Canadian Alteplase for Stroke Effectiveness St
Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis
Diabetes Care, April 1, 2009; 32(4): 617 - 622.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Fuentes, J. Castillo, B. San Jose, R. Leira, J. Serena, J. Vivancos, A. Davalos, A. G. Nunez, J. Egido, E. Diez-Tejedor, et al.
The Prognostic Value of Capillary Glucose Levels in Acute Stroke: The GLycemia in Acute Stroke (GLIAS) Study
Stroke, February 1, 2009; 40(2): 562 - 568.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Yong and M. Kaste
Dynamic of Hyperglycemia as a Predictor of Stroke Outcome in the ECASS-II Trial
Stroke, October 1, 2008; 39(10): 2749 - 2755.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. T. McCormick, K. W. Muir, C. S. Gray, and M. R. Walters
Management of Hyperglycemia in Acute Stroke: How, When, and for Whom?
Stroke, July 1, 2008; 39(7): 2177 - 2185.
[Full Text] [PDF]


Home page
NeurologyHome page
A. A. Wong, P. J. Schluter, R. D. Henderson, J. D. O'Sullivan, and S. J. Read
Natural history of blood glucose within the first 48 hours after ischemic stroke
Neurology, March 25, 2008; 70(13): 1036 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Intl J Care PathwHome page
S. Chew, S. A Kausar, and S. Sturman
Thrombolysis in acute ischaemic stroke pathway
Intl J Care Pathw, January 1, 2008; 12(1): 10 - 22.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. A. Kent and P. Mandava
Recanalization Rates Can Be Misleading
Stroke, October 1, 2007; 38(10): e103 - e103.
[Full Text] [PDF]


Home page
BrainHome page
M. Uyttenboogaart, M. W. Koch, R. E. Stewart, P. C. Vroomen, G.-J. Luijckx, and J. De Keyser
Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke
Brain, June 1, 2007; 130(6): 1626 - 1630.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Garg, A. Chaudhuri, F. Munschauer, and P. Dandona
Hyperglycemia, Insulin, and Acute Ischemic Stroke: A Mechanistic Justification for a Trial of Insulin Infusion Therapy
Stroke, January 1, 2006; 37(1): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 9: Adult Stroke
Circulation, December 13, 2005; 112(24_suppl): IV-111 - IV-120.
[Full Text] [PDF]


Home page
CirculationHome page
Part 9: Stroke
Circulation, November 29, 2005; 112(22_suppl): III-110 - III-104.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. E. Anderson, K. Brismar, G. Barr, and T. Ivert
Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery
Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 425 - 430.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
O. O. Zaidat, J. I. Suarez, J. L. Sunshine, R. W. Tarr, M. J. Alexander, T. P. Smith, D. S. Enterline, W. R. Selman, and D. M. D. Landis
Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 880 - 884.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Ribo, C. A. Molina, A. Rovira, M. Quintana, P. Delgado, J. Montaner, E. Grive, J. F. Arenillas, and J. Alvarez-Sabin
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke, March 1, 2005; 36(3): 602 - 606.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. O. Roine and P. J. Lindsberg
Editorial Comment--Prime Time for Proactive Blood Glucose Control?
Stroke, November 1, 2004; 35(11): 2498 - 2499.
[Full Text] [PDF]


Home page
StrokeHome page
J. Alvarez-Sabin, C. A. Molina, M. Ribo, J. F. Arenillas, J. Montaner, R. Huertas, E. Santamarina, and M. Rubiera
Impact of Admission Hyperglycemia on Stroke Outcome After Thrombolysis: Risk Stratification in Relation to Time to Reperfusion
Stroke, November 1, 2004; 35(11): 2493 - 2498.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Saposnik, B. Young, B. Silver, S. Di Legge, F. Webster, V. Beletsky, V. Jain, Y. Nilanont, and V. Hachinski
Lack of Improvement in Patients With Acute Stroke After Treatment With Thrombolytic Therapy: Predictors and Association With Outcome
JAMA, October 20, 2004; 292(15): 1839 - 1844.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Leigh, O. O. Zaidat, M. F. Suri, G. Lynch, S. Sundararajan, J. L. Sunshine, R. Tarr, W. Selman, D. M.D. Landis, and J. I. Suarez
Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke, August 1, 2004; 35(8): 1903 - 1907.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. J. Lindsberg and R. O. Roine
Hyperglycemia in Acute Stroke
Stroke, February 1, 2004; 35(2): 363 - 364.
[Full Text] [PDF]